{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:45:45Z","timestamp":1791827145914,"version":"4.3.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-025-01478-2","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:22:55Z","timestamp":1745324575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structure\u2013activity relationship guided design, synthesis and biological evaluation of novel diaryl urea derivatives as antiproliferative agents"],"prefix":"10.1186","volume":"19","author":[{"given":"Fereshteh","family":"Azimian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Cheshmazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges Hosseini","family":"Nasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok Su","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Ja","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrokh","family":"Dastmalchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavoush","family":"Dastmalchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"3","key":"1478_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag. 2006;2(3):213\u20139.","journal-title":"Vasc Health Risk Manag"},{"key":"1478_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0974-6","volume":"18","author":"M Yi","year":"2019","unstructured":"Yi M, Jiao D, Qin S, Chu Q, Wu K, Li A. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment. Mol Cancer. 2019;18:1\u201312.","journal-title":"Mol Cancer"},{"key":"1478_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fonc.2019.01399","volume":"9","author":"D Aguilar-Cazares","year":"2019","unstructured":"Aguilar-Cazares D, Chavez-Dominguez R, Carlos-Reyes A, Lopez-Camarillo C, Hernadez de la Cruz ON, Lopez-Gonzalez JS. Contribution of angiogenesis to inflammation and cancer. Front Oncol. 2019;9:1399.","journal-title":"Front Oncol"},{"issue":"4","key":"1478_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6(4):273\u201386.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"1478_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2174\/0929867323666160210130426","volume":"23","author":"L Shi","year":"2016","unstructured":"Shi L, Zhou J, Wu J, Shen Y, Li X. Anti-angiogenic therapy: Strategies to develop potent VEGFR-2 tyrosine kinase inhibitors and future prospect. Curr Med Chem. 2016;23(10):1000\u201340.","journal-title":"Curr Med Chem"},{"issue":"4","key":"1478_CR6","first-page":"779","volume":"2","author":"J Furuse","year":"2008","unstructured":"Furuse J. Sorafenib for the treatment of unresectable hepatocellular carcinoma. Biologics. 2008;2(4):779\u201388.","journal-title":"Biologics"},{"issue":"24","key":"1478_CR7","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-06-1249","volume":"12","author":"RC Kane","year":"2006","unstructured":"Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM, et al. Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res. 2006;12(24):7271\u20138.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1478_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.22270\/ajprd.v7i6.616","volume":"7","author":"AB Deore","year":"2019","unstructured":"Deore AB, Dhumane JR, Wagh R, Sonawane R. The stages of drug discovery and development process. Asian J Pharm Res Dev. 2019;7(6):62\u20137.","journal-title":"Asian J Pharm Res Dev"},{"key":"1478_CR9","volume-title":"Methods in molecular biology","author":"R Guha","year":"2013","unstructured":"Guha R. On exploring structure-activity relationships. In: Methods in molecular biology. Totowa: Humana Press; 2013."},{"key":"1478_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112461","volume":"201","author":"F Azimian","year":"2020","unstructured":"Azimian F, Hamzeh-Mivehroud M, Mojarrad JS, Hemmati S, Dastmalchi S. Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach. Eur J Med Chem. 2020;201: 112461.","journal-title":"Eur J Med Chem"},{"key":"1478_CR11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/s00044-020-02559-8","volume":"29","author":"O Zarei","year":"2020","unstructured":"Zarei O, Azimian F, Hamzeh-Mivehroud M, Shahbazi Mojarrad J, Hemmati S, Dastmalchi S. Design, synthesis, and biological evaluation of novel benzo [b] thiophene-diaryl urea derivatives as potential anticancer agents. Med Chem Res. 2020;29:1438\u201348.","journal-title":"Med Chem Res"},{"key":"1478_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00044-020-02673-7","volume":"30","author":"F Azimian","year":"2021","unstructured":"Azimian F, Hamzeh-Mivehroud M, Shahbazi Mojarrad J, Hemmati S, Dastmalchi S. Facile one-pot sequential synthesis of novel diaryl urea derivatives and evaluation of their in vitro cytotoxicity on adenocarcinoma cells. Med Chem Res. 2021;30:672\u201384.","journal-title":"Med Chem Res"},{"issue":"45","key":"1478_CR13","doi-asserted-by":"publisher","first-page":"18281","DOI":"10.1073\/pnas.1207759109","volume":"109","author":"M McTigue","year":"2012","unstructured":"McTigue M, Murray BW, Chen JH, Deng Y-L, Solowiej J, Kania RS. Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proc Natl Acad Sci. 2012;109(45):18281\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"1478_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25(9):1157\u201374.","journal-title":"J Comput Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01478-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01478-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01478-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:22:56Z","timestamp":1745324576000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01478-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01478-2","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}